tiprankstipranks
Trending News
More News >
MapLight Therapeutics, Inc. (MPLT)
NASDAQ:MPLT
US Market

MapLight Therapeutics, Inc. (MPLT) Income Statement

Compare
5 Followers

MapLight Therapeutics, Inc. Income Statement

Last quarter (Q3 2025), MapLight Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, MapLight Therapeutics, Inc.'s net income was $-29.42M. See MapLight Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ -701.00K$ -556.00K$ -574.00K
Operating Expenses
$ 82.25M$ 56.73M$ 30.67M
Depreciation and Amortization
$ 701.00K$ 556.00K$ 574.00K
EBITDA
$ -76.88M$ -55.15M$ -29.44M
Operating Income
$ -82.95M$ -57.28M$ -31.25M
Other Income/Expenses
$ 5.37M$ 1.57M$ 1.23M
Pretax Income
$ -77.58M$ -55.71M$ -30.02M
Net Income
$ -77.58M$ -55.71M$ -30.02M
Per Share Metrics
Basic EPS
$ -1.87$ -1.34$ -0.72
Diluted EPS
$ -1.87$ -1.34$ -0.72
Weighted Average Shares Outstanding
41.43M 41.43M 41.43M
Weighted Average Shares Outstanding (Diluted)
41.43M 41.43M 41.43M
Currency in USD

MapLight Therapeutics, Inc. Earnings and Revenue History